Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,MED and Pseudoachondroplasia genes WP4789,0.001140194851841907,inf,inf,"['MATN1', 'COL9A3']",0.27706734899758345,0,0,2
2,Purine metabolism WP4792,0.0027682760386414924,14.376857749469215,84.67294251525738,"['ATIC', 'HPRT1', 'ADSS']",0.3363455386949413,0,0,3
3,Metapathway biotransformation Phase I and II WP702,0.010379953107579932,2.854448153446723,13.038773545019044,"['SULT1A1', 'NDST1', 'CYP4X1', 'GSTA4', 'MGST3', 'AKR1A1', 'CYP2C18', 'HS3ST2']",0.8058841812359887,0,0,8
4,Ciliary landscape WP4352,0.01590411567243721,2.0596470016476416,8.529363524428305,"['EIF5B', 'DYNLT1', 'EIPR1', 'COPS7B', 'IFT122', 'EXOSC7', 'RMND5B', 'DNPEP', 'TIPRL', 'TNKS1BP1', 'IFT27', 'CLUAP1', 'BBS4']",0.8058841812359887,0,0,13
5,Purine metabolism and related disorders WP4224,0.01833334200914824,6.157870791628754,24.62553410414403,"['ATIC', 'HPRT1', 'ADSS']",0.8058841812359887,0,0,3
6,Genes related to primary cilium development (based on CRISPR) WP4536,0.019898374845333053,2.5111028176898675,9.836284079951835,"['DYNLT1', 'ARL6', 'TCTN3', 'IFT122', 'IFT27', 'TUBD1', 'CLUAP1', 'BBS4']",0.8058841812359887,0,0,8
7,Mitochondrial CII Assembly WP4920,0.027888243518720778,9.564265536723164,34.23576725878335,"['SDHAF4', 'SDHD']",0.9626517377585815,0,0,2
8,Fluoropyrimidine Activity WP1601,0.050880709532247534,3.9163288940359005,11.663890396212166,"['ABCC4', 'ERCC2', 'CES2']",0.9626517377585815,0,0,3
9,Intraflagellar transport proteins binding to dynein WP4532,0.061614499712222874,3.5894373673036095,10.003252426357772,"['DYNLT1', 'IFT122', 'IFT27']",0.9626517377585815,0,0,3
10,Arylamine metabolism WP694,0.06646274661040334,28.642706131078224,77.65363270027447,['SULT1A1'],0.9626517377585815,0,0,1
11,Non-small cell lung cancer WP4255,0.07203162781677588,2.3573001503023523,6.201231596043118,"['ALK', 'CRABP2', 'GADD45A', 'E2F3', 'JAK3']",0.9626517377585815,0,0,5
12,Kallmann's Syndrome WP5074,0.10017587106988074,4.096549636803874,9.425455808765687,"['CHD7', 'ANOS1']",0.9626517377585815,0,0,2
13,Nephrotic syndrome WP4758,0.10636210832136878,2.777480994452435,6.224073520668246,"['NPHS1', 'E2F3', 'ACTN4']",0.9626517377585815,0,0,3
14,Spinal Cord Injury WP2431,0.1095520848340504,2.0528480048735913,4.539576073910363,"['GADD45A', 'PTPRA', 'SLIT1', 'NOX4', 'E2F5']",0.9626517377585815,0,0,5
15,Globo Sphingolipid Metabolism WP1424,0.12229185794638738,3.5839512711864407,7.531117413544231,"['ST6GAL1', 'FUT9']",0.9626517377585815,0,0,2
16,Irinotecan pathway WP229,0.12851703374811047,9.5461592670895,19.585796021526242,['CES2'],0.9626517377585815,0,0,1
17,"Phase I biotransformations, non P450 WP136",0.12851703374811047,9.5461592670895,19.585796021526242,['CES2'],0.9626517377585815,0,0,1
18,Monoamine GPCRs WP58,0.13375473842493435,3.3728813559322033,6.785385522120771,"['HRH1', 'HTR1F']",0.9626517377585815,0,0,2
19,Nucleotide metabolism WP404,0.13375473842493435,3.3728813559322033,6.785385522120771,"['HPRT1', 'ADSS']",0.9626517377585815,0,0,2
20,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.1454466300995768,3.1852636534839927,6.14101652066604,"['NMNAT2', 'ELAVL1']",0.9626517377585815,0,0,2
21,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.15798292528110153,7.159090909090909,13.210443651939903,['CYP2C18'],0.9626517377585815,0,0,1
22,Metastatic brain tumor WP2249,0.15798292528110153,7.159090909090909,13.210443651939903,['E2F3'],0.9626517377585815,0,0,1
23,mir-124 predicted interactions with cell cycle and differentiation  WP3595,0.15798292528110153,7.159090909090909,13.210443651939903,['SIX4'],0.9626517377585815,0,0,1
24,Mitochondrial fatty acid synthesis pathway WP4317,0.15798292528110153,7.159090909090909,13.210443651939903,['MECR'],0.9626517377585815,0,0,1
25,Tamoxifen metabolism WP691,0.18645457159059112,5.726849894291755,9.61863183909886,['SULT1A1'],0.9626517377585815,0,0,1
26,Benzo(a)pyrene metabolism WP696,0.18645457159059112,5.726849894291755,9.61863183909886,['AKR1A1'],0.9626517377585815,0,0,1
27,Drug Induction of Bile Acid Pathway WP2289,0.18645457159059112,5.726849894291755,9.61863183909886,['ABCC4'],0.9626517377585815,0,0,1
28,exRNA mechanism of action and biogenesis WP2805,0.18645457159059112,5.726849894291755,9.61863183909886,['AGO2'],0.9626517377585815,0,0,1
29,Pre-implantation embryo WP3527,0.19395891183223354,2.6053543913713404,4.273065021417652,"['E2F5', 'ELAVL1']",0.9626517377585815,0,0,2
30,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.21396545118702356,4.772022551092318,7.358175888501836,['MEF2C'],0.9626517377585815,0,0,1
31,Sulfation Biotransformation Reaction WP692,0.21396545118702356,4.772022551092318,7.358175888501836,['SULT1A1'],0.9626517377585815,0,0,1
32,Aspirin and miRNAs WP4707,0.21396545118702356,4.772022551092318,7.358175888501836,['ABCC4'],0.9626517377585815,0,0,1
33,Cell Differentiation - Index WP2029,0.21396545118702356,4.772022551092318,7.358175888501836,['MEF2C'],0.9626517377585815,0,0,1
34,Estrogen metabolism WP697,0.21396545118702356,4.772022551092318,7.358175888501836,['SULT1A1'],0.9626517377585815,0,0,1
35,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.21396545118702356,4.772022551092318,7.358175888501836,['BLVRA'],0.9626517377585815,0,0,1
36,Oxidation by Cytochrome P450 WP43,0.21892348476168666,2.387888418079096,3.627281295116956,"['CYP4X1', 'CYP2C18']",0.9626517377585815,0,0,2
37,Mitochondrial complex I assembly model OXPHOS system WP4324,0.2385484768086407,1.8297872340425532,2.6224194675182915,"['ACAD9', 'NDUFV3', 'NDUFV2']",0.9626517377585815,0,0,3
38,"Degradation pathway of sphingolipids, including diseases WP4153",0.24054791803400385,4.090003020235578,5.827583403863166,['NEU3'],0.9626517377585815,0,0,1
39,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.24054791803400385,4.090003020235578,5.827583403863166,['CUL2'],0.9626517377585815,0,0,1
40,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.2567868045288438,1.7548420642142206,2.3857237425868023,"['CSNK2A1', 'ELAVL1', 'CXXC4']",0.9626517377585815,0,0,3
41,Vitamin A and carotenoid metabolism WP716,0.2567902787954278,2.1220966729441306,2.884981011211289,"['SULT1A1', 'CRABP2']",0.9626517377585815,0,0,2
42,Serotonin and anxiety-related events WP3944,0.2662332389952676,3.578488372093023,4.735708945589568,['CRHR1'],0.9626517377585815,0,0,1
43,Autosomal recessive Osteopetrosis pathways WP4788,0.2662332389952676,3.578488372093023,4.735708945589568,['TNFRSF11A'],0.9626517377585815,0,0,1
44,Biotin Metabolism (including IEMs) WP5031,0.2662332389952676,3.578488372093023,4.735708945589568,['MCCC2'],0.9626517377585815,0,0,1
45,Thiamine metabolic pathways WP4297,0.2662332389952676,3.578488372093023,4.735708945589568,['SLC25A19'],0.9626517377585815,0,0,1
46,Genes targeted by miRNAs in adipocytes WP1992,0.2662332389952676,3.578488372093023,4.735708945589568,['HCN4'],0.9626517377585815,0,0,1
47,Matrix Metalloproteinases WP129,0.2662332389952676,3.578488372093023,4.735708945589568,['MMP15'],0.9626517377585815,0,0,1
48,IL-2 signaling pathway WP49,0.2821129392696895,1.9754529514903565,2.4998325803177943,"['MAPT', 'JAK3']",0.9626517377585815,0,0,2
49,Osteoclast Signaling WP12,0.2910516302147804,3.180643645759925,3.92572406387547,['TNFRSF11A'],0.9626517377585815,0,0,1
50,Ciliopathies WP4803,0.29206674338144245,1.3211287050602953,1.6260094467170978,"['PLK4', 'ARL6', 'TCTN3', 'IFT122', 'IFT27', 'CLUAP1', 'BBS4']",0.9626517377585815,0,0,7
51,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.30735935287992877,1.8477310005467469,2.179837893786538,"['SMAD3', 'FBXO32']",0.9626517377585815,0,0,2
52,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.3150322923268033,2.862367864693446,3.3062642455088307,['SYTL2'],0.9626517377585815,0,0,1
53,Disorders of Folate Metabolism and Transport WP4259,0.3150322923268033,2.862367864693446,3.3062642455088307,['ATIC'],0.9626517377585815,0,0,1
54,FOXA2 pathway WP5066,0.3150322923268033,2.862367864693446,3.3062642455088307,['ABCC4'],0.9626517377585815,0,0,1
55,GDNF/RET signaling axis WP4830,0.3150322923268033,2.862367864693446,3.3062642455088307,['IFT27'],0.9626517377585815,0,0,1
56,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.3150322923268033,2.862367864693446,3.3062642455088307,['H2AFY'],0.9626517377585815,0,0,1
57,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.3150322923268033,2.862367864693446,3.3062642455088307,['JAK3'],0.9626517377585815,0,0,1
58,ATM Signaling Pathway WP2516,0.3199216795663561,1.7898569915254237,2.0398625416904848,"['GADD45A', 'TP53BP1']",0.9626517377585815,0,0,2
59,Proximal tubule transport WP4917,0.3199216795663561,1.7898569915254237,2.0398625416904848,"['ABCC4', 'SLC4A4']",0.9626517377585815,0,0,2
60,NRF2 pathway WP2884,0.3314542766145128,1.397716658017644,1.5434501551225934,"['ABCC4', 'GSTA4', 'MGST3', 'CES2']",0.9626517377585815,0,0,4
61,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.3382034444391884,2.601960407457236,2.820805203400423,['SMAD3'],0.9626517377585815,0,0,1
62,Canonical and non-canonical TGF-B signaling WP3874,0.3382034444391884,2.601960407457236,2.820805203400423,['SMAD3'],0.9626517377585815,0,0,1
63,Cell Differentiation - Index expanded WP2023,0.3382034444391884,2.601960407457236,2.820805203400423,['MEF2C'],0.9626517377585815,0,0,1
64,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.3382034444391884,2.601960407457236,2.820805203400423,['SORBS2'],0.9626517377585815,0,0,1
65,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.33917369783588214,1.380774160471674,1.492952284891903,"['COX15', 'SDHD', 'NDUFV3', 'NDUFV2']",0.9626517377585815,0,0,4
66,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.34486768964171416,1.6843220338983051,1.7931198788475635,"['SMAD3', 'TRAF5']",0.9626517377585815,0,0,2
67,Male infertility WP4673,0.35462754992641,1.3480851063829786,1.397542568086021,"['GNAO1', 'AGO2', 'ERCC2', 'MOV10L1']",0.9626517377585815,0,0,4
68,Biomarkers for pyrimidine metabolism disorders WP4584,0.3605923570504371,2.384954193093728,2.432670361641365,['PUS1'],0.9626517377585815,0,0,1
69,TP53 network WP1742,0.3605923570504371,2.384954193093728,2.432670361641365,['GADD45A'],0.9626517377585815,0,0,1
70,Tryptophan catabolism leading to NAD+ production WP4210,0.3605923570504371,2.384954193093728,2.432670361641365,['NMNAT2'],0.9626517377585815,0,0,1
71,"GPCRs, Class B Secretin-like WP334",0.3605923570504371,2.384954193093728,2.432670361641365,['CRHR1'],0.9626517377585815,0,0,1
72,IL-9 signaling pathway WP22,0.3605923570504371,2.384954193093728,2.432670361641365,['JAK3'],0.9626517377585815,0,0,1
73,Myometrial relaxation and contraction pathways WP289,0.36209028850024033,1.2790321352421565,1.2993197368898972,"['GNG7', 'IGFBP2', 'GRK6', 'RGS20', 'CRHR1']",0.9626517377585815,0,0,5
74,Calcium Regulation in the Cardiac Cell WP536,0.368835732565539,1.2676189218257636,1.264328060472608,"['GNAO1', 'KCNB1', 'GNG7', 'GRK6', 'RGS20']",0.9626517377585815,0,0,5
75,Regulation of Microtubule Cytoskeleton WP2038,0.38169319954184083,1.5474118185982593,1.490371334013405,"['PTPRA', 'MAPT']",0.9626517377585815,0,0,2
76,Imatinib and Chronic Myeloid Leukemia WP3640,0.3822253840007106,2.2013335501707596,2.1171211695459973,['GADD45A'],0.9626517377585815,0,0,1
77,MAPK pathway in congenital thyroid cancer WP4928,0.3822253840007106,2.2013335501707596,2.1171211695459973,['ALK'],0.9626517377585815,0,0,1
78,NAD+ metabolism WP3644,0.3822253840007106,2.2013335501707596,2.1171211695459973,['NMNAT2'],0.9626517377585815,0,0,1
79,Riboflavin and CoQ disorders WP5037,0.3822253840007106,2.2013335501707596,2.1171211695459973,['COQ7'],0.9626517377585815,0,0,1
80,Histone Modifications WP2369,0.3937759651857088,1.506578947368421,1.4040911238189324,"['PRDM2', 'KMT5A']",0.9626517377585815,0,0,2
81,Cell cycle WP179,0.40089103843110424,1.2586392331073182,1.1504788424205326,"['SMAD3', 'GADD45A', 'E2F3', 'E2F5']",0.9626517377585815,0,0,4
82,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.4050879313332822,1.321313081822636,1.194006047631666,"['NPY', 'TTF2', 'MGLL']",0.9626517377585815,0,0,3
83,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.4176095230216749,1.4310381355932202,1.24959457581966,"['SMAD3', 'AGO2']",0.9626517377585815,0,0,2
84,mRNA Processing WP411,0.4226778282056392,1.1831045480977638,1.0188245963297302,"['DHX8', 'CLP1', 'SRP54', 'SNRPA1', 'RBMX']",0.9626517377585815,0,0,5
85,Urea cycle and metabolism of amino groups WP497,0.42332479532903444,1.9075405214940098,1.6397515077221723,['SMS'],0.9626517377585815,0,0,1
86,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.42332479532903444,1.9075405214940098,1.6397515077221723,['THRAP3'],0.9626517377585815,0,0,1
87,Pregnane X receptor pathway WP2876,0.42332479532903444,1.9075405214940098,1.6397515077221723,['ABCC4'],0.9626517377585815,0,0,1
88,Copper homeostasis WP3286,0.42934793054112186,1.396031417941298,1.180327339433183,"['CCS', 'MAPT']",0.9626517377585815,0,0,2
89,Corticotropin-releasing hormone signaling pathway WP2355,0.43230377135327747,1.2627388535031847,1.0589665977586225,"['GNAO1', 'GRK6', 'CRHR1']",0.9626517377585815,0,0,3
90,IL-4 signaling pathway WP395,0.44096006954478756,1.3626916868442291,1.1157732516760792,"['HRH1', 'JAK3']",0.9626517377585815,0,0,2
91,Nucleotide Excision Repair WP4753,0.44096006954478756,1.3626916868442291,1.1157732516760792,"['LIG1', 'ERCC2']",0.9626517377585815,0,0,2
92,Constitutive Androstane Receptor Pathway WP2875,0.4428395749281215,1.7881871035940804,1.4565637064720585,['SULT1A1'],0.9626517377585815,0,0,1
93,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.4428395749281215,1.7881871035940804,1.4565637064720585,['SMAD3'],0.9626517377585815,0,0,1
94,Purinergic signaling WP4900,0.4428395749281215,1.7881871035940804,1.4565637064720585,['GNAO1'],0.9626517377585815,0,0,1
95,Pathways Regulating Hippo Signaling WP4540,0.45019421331381176,1.2264786169244768,0.9788233991055335,"['SMAD3', 'GNAL', 'CDH9']",0.9626517377585815,0,0,3
96,RANKL/RANK signaling pathway WP2018,0.45244105686433655,1.330902640914466,1.0555359370924822,"['TRAF5', 'TNFRSF11A']",0.9626517377585815,0,0,2
97,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.4616953158808908,1.682875264270613,1.300610307687174,['SDHD'],0.9626517377585815,0,0,1
98,TYROBP causal network in microglia WP3945,0.4616953158808908,1.682875264270613,1.300610307687174,['ABCC4'],0.9626517377585815,0,0,1
99,Vitamin D in inflammatory diseases WP4482,0.4616953158808908,1.682875264270613,1.300610307687174,['SMAD3'],0.9626517377585815,0,0,1
100,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.4616953158808908,1.682875264270613,1.300610307687174,['H2AFY'],0.9626517377585815,0,0,1
101,Heart Development WP1591,0.4616953158808908,1.682875264270613,1.300610307687174,['MEF2C'],0.9626517377585815,0,0,1
102,Methionine De Novo and Salvage Pathway WP3580,0.4616953158808908,1.682875264270613,1.300610307687174,['SMS'],0.9626517377585815,0,0,1
103,Monoamine Transport WP727,0.4616953158808908,1.682875264270613,1.300610307687174,['FBXO32'],0.9626517377585815,0,0,1
104,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.4616953158808908,1.682875264270613,1.300610307687174,['ABCC4'],0.9626517377585815,0,0,1
105,p53 transcriptional gene network WP4963,0.47499238144399564,1.271563088512241,0.9466234243846896,"['GADD45A', 'SESN2']",0.9626517377585815,0,0,2
106,Rett syndrome causing genes WP4312,0.47499238144399564,1.271563088512241,0.9466234243846896,"['GNAO1', 'MEF2C']",0.9626517377585815,0,0,2
107,Striated Muscle Contraction Pathway WP383,0.4799142291542049,1.589264740427531,1.166755340434867,['ACTN4'],0.9626517377585815,0,0,1
108,IL-7 signaling pathway WP205,0.4799142291542049,1.589264740427531,1.166755340434867,['JAK3'],0.9626517377585815,0,0,1
109,Ovarian infertility WP34,0.4799142291542049,1.589264740427531,1.166755340434867,['SMAD3'],0.9626517377585815,0,0,1
110,Genotoxicity pathway WP4286,0.48605521235180255,1.243828297715549,0.8973388498011614,"['COIL', 'GADD45A']",0.9626517377585815,0,0,2
111,Notch Signaling Pathway Netpath WP61,0.48605521235180255,1.243828297715549,0.8973388498011614,"['CIR1', 'MAPT']",0.9626517377585815,0,0,2
112,G1 to S cell cycle control WP45,0.4969718299864757,1.217273710782546,0.8511444789905827,"['GADD45A', 'E2F3']",0.9626517377585815,0,0,2
113,Genes controlling nephrogenesis WP4823,0.49751777883980297,1.5055079559363524,1.051031216147545,['NPHS1'],0.9626517377585815,0,0,1
114,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.49751777883980297,1.5055079559363524,1.051031216147545,['TNFRSF11A'],0.9626517377585815,0,0,1
115,SARS-CoV-2 mitochondrial interactions WP5038,0.49751777883980297,1.5055079559363524,1.051031216147545,['ACAD9'],0.9626517377585815,0,0,1
116,MAPK Signaling Pathway WP382,0.5007929411554388,1.0539051053758592,0.7288413068031706,"['PPP5D1', 'MEF2C', 'PTPRR', 'GADD45A', 'PLA2G4C', 'MAPT', 'CACNG3']",0.9626517377585815,0,0,7
117,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.5077394643434328,1.1918255649717515,0.8078036697237764,"['NPHS1', 'ACTN4']",0.9626517377585815,0,0,2
118,Small cell lung cancer WP4658,0.5108265549976597,1.1144015220448342,0.7485715508414476,"['GADD45A', 'TRAF5', 'E2F3']",0.9626517377585815,0,0,3
119,Pancreatic adenocarcinoma pathway WP4263,0.5108265549976597,1.1144015220448342,0.7485715508414476,"['SMAD3', 'GADD45A', 'E2F3']",0.9626517377585815,0,0,3
120,Sphingolipid Metabolism (general overview) WP4725,0.5145267069762788,1.4301268498942918,0.9503304702728748,['DEGS2'],0.9626517377585815,0,0,1
121,Cardiac Progenitor Differentiation WP2406,0.5145267069762788,1.4301268498942918,0.9503304702728748,['MEF2C'],0.9626517377585815,0,0,1
122,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.5145267069762788,1.4301268498942918,0.9503304702728748,['TNFRSF11A'],0.9626517377585815,0,0,1
123,Differentiation Pathway WP2848,0.5145267069762788,1.4301268498942918,0.9503304702728748,['ALK'],0.9626517377585815,0,0,1
124,Fatty Acid Biosynthesis WP357,0.5145267069762788,1.4301268498942918,0.9503304702728748,['MECR'],0.9626517377585815,0,0,1
125,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.5145267069762788,1.4301268498942918,0.9503304702728748,['GRK6'],0.9626517377585815,0,0,1
126,Oxidative phosphorylation WP623,0.5183556986782362,1.1674161189899688,0.7671016549461721,"['NDUFV3', 'NDUFV2']",0.9626517377585815,0,0,2
127,G Protein Signaling Pathways WP35,0.519202078506233,1.1000326637269313,0.7210297311807816,"['GNAO1', 'GNAL', 'GNG7']",0.9626517377585815,0,0,3
128,Sphingolipid Metabolism (integrated pathway) WP4726,0.530961058047568,1.3619248968086177,0.8621891603910707,['DEGS2'],0.9626517377585815,0,0,1
129,Unfolded protein response WP4925,0.530961058047568,1.3619248968086177,0.8621891603910707,['RTCB'],0.9626517377585815,0,0,1
130,DNA Mismatch Repair WP531,0.530961058047568,1.3619248968086177,0.8621891603910707,['LIG1'],0.9626517377585815,0,0,1
131,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.530961058047568,1.3619248968086177,0.8621891603910707,['SMAD3'],0.9626517377585815,0,0,1
132,Nanoparticle triggered autophagic cell death WP2509,0.530961058047568,1.3619248968086177,0.8621891603910707,['CHAF1A'],0.9626517377585815,0,0,1
133,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.5391259433194016,1.1214689265536724,0.6928503149553509,"['ACTN4', 'CACNG3']",0.9626517377585815,0,0,2
134,Gastric Cancer Network 2 WP2363,0.5468402019355474,1.2999231212761868,0.7846318471393058,['COL9A3'],0.9626517377585815,0,0,1
135,MET in type 1 papillary renal cell carcinoma WP4205,0.5592695346492893,1.0789894467540775,0.6270263925783625,"['ALK', 'JAK3']",0.9626517377585815,0,0,2
136,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.5621828571665688,1.2433128044857065,0.7160587978355499,['RAB4B'],0.9626517377585815,0,0,1
137,Neovascularisation processes WP4331,0.5621828571665688,1.2433128044857065,0.7160587978355499,['SMAD3'],0.9626517377585815,0,0,1
138,One-carbon metabolism WP241,0.5621828571665688,1.2433128044857065,0.7160587978355499,['ATIC'],0.9626517377585815,0,0,1
139,Oxidative Stress WP408,0.5621828571665688,1.2433128044857065,0.7160587978355499,['NOX4'],0.9626517377585815,0,0,1
140,Photodynamic therapy-induced unfolded protein response WP3613,0.5621828571665688,1.2433128044857065,0.7160587978355499,['EIF2A'],0.9626517377585815,0,0,1
141,Tryptophan metabolism WP465,0.5770071122804846,1.1914200140944327,0.6551626833514016,['CYP2C18'],0.9626517377585815,0,0,1
142,Ethanol effects on histone modifications WP3996,0.5770071122804846,1.1914200140944327,0.6551626833514016,['ELP3'],0.9626517377585815,0,0,1
143,Glycosylation and related congenital defects WP4521,0.5770071122804846,1.1914200140944327,0.6551626833514016,['ALG13'],0.9626517377585815,0,0,1
144,The influence of laminopathies on Wnt signaling WP4844,0.5913304472830564,1.1436786469344609,0.6008662139022446,['AGO2'],0.9626517377585815,0,0,1
145,Development of ureteric collection system WP5053,0.5913304472830564,1.1436786469344609,0.6008662139022446,['ANOS1'],0.9626517377585815,0,0,1
146,Endothelin Pathways WP2197,0.5913304472830564,1.1436786469344609,0.6008662139022446,['NPY'],0.9626517377585815,0,0,1
147,Lipid Metabolism Pathway WP3965,0.5913304472830564,1.1436786469344609,0.6008662139022446,['HILPDA'],0.9626517377585815,0,0,1
148,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.5976462626106483,1.0029735355337497,0.5162868801062024,"['CSNK2A1', 'CXXC4']",0.9626517377585815,0,0,2
149,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.6051697540216511,1.0996096926329484,0.552274872241751,['RIPK2'],0.9626517377585815,0,0,1
150,Prostaglandin Synthesis and Regulation WP98,0.6051697540216511,1.0996096926329484,0.552274872241751,['ABCC4'],0.9626517377585815,0,0,1
151,Adipogenesis WP236,0.6058380119641362,0.9632863379374508,0.4827438542657183,"['MEF2C', 'SMAD3', 'GADD45A']",0.9626517377585815,0,0,3
152,Melanoma WP4685,0.6068399557292102,0.9856078316773816,0.4923014402076382,"['GADD45A', 'E2F3']",0.9626517377585815,0,0,2
153,Prion disease pathway WP3995,0.6185413557188744,1.0588051053167333,0.5086406814136549,['MEF2C'],0.9626517377585815,0,0,1
154,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6247469789201202,0.9526129943502825,0.44811729256405264,"['GNAO1', 'TTF2']",0.9626517377585815,0,0,2
155,Melatonin metabolism and effects WP3298,0.6314610263603571,1.0209151313802476,0.4693341395082284,['SULT1A1'],0.9626517377585815,0,0,1
156,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.6420163472657232,0.9217468562055768,0.4084642960799902,"['SMAD3', 'GADD45A']",0.9626517377585815,0,0,2
157,Base Excision Repair WP4752,0.6439440090667836,0.9856382590945542,0.43382227220508335,['LIG1'],0.9626517377585815,0,0,1
158,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.6439440090667836,0.9856382590945542,0.43382227220508335,['IGFBP2'],0.9626517377585815,0,0,1
159,IL-5 signaling pathway WP127,0.6560050338090441,0.9527131782945737,0.4016513159492061,['MAPT'],0.9626517377585815,0,0,1
160,Oxidative Damage WP3941,0.6560050338090441,0.9527131782945737,0.4016513159492061,['GADD45A'],0.9626517377585815,0,0,1
161,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.6676583346791083,0.9219122962558821,0.3724329413958823,['TRAF5'],0.9626517377585815,0,0,1
162,Mitochondrial CIV Assembly WP4922,0.6676583346791083,0.9219122962558821,0.3724329413958823,['COX15'],0.9626517377585815,0,0,1
163,Endoderm differentiation WP2853,0.6685770761777715,0.8742363187313141,0.3519706820792877,"['SMAD3', 'HPRT1', 'ELAVL1']",0.9626517377585815,0,0,3
164,Amyotrophic lateral sclerosis (ALS) WP2447,0.678917666625062,0.8930364693446089,0.3458332090704281,['CCS'],0.9626517377585815,0,0,1
165,Type 2 papillary renal cell carcinoma WP4241,0.678917666625062,0.8930364693446089,0.3458332090704281,['CUL2'],0.9626517377585815,0,0,1
166,Ferroptosis WP4313,0.6897963215918707,0.8659106925491703,0.3215636518650867,['LPCAT3'],0.9626517377585815,0,0,1
167,Joubert Syndrome WP4656,0.6900634580688851,0.840042372881356,0.3116319617598217,"['TCTN3', 'BBS4']",0.9626517377585815,0,0,2
168,Retinoblastoma gene in cancer WP2446,0.6900634580688851,0.840042372881356,0.3116319617598217,"['PLK4', 'E2F3']",0.9626517377585815,0,0,2
169,Chemokine signaling pathway WP3929,0.6940142929786272,0.8397027600849257,0.30671211717761787,"['GNG7', 'GRK6', 'JAK3']",0.9626517377585815,0,0,3
170,VEGFA-VEGFR2 Signaling Pathway WP3888,0.6975480714928162,0.8829982052140054,0.31804169129443655,"['MEF2C', 'TFCP2', 'FBXW11', 'GIPC1', 'RCAN2', 'CTNND1', 'DHX36', 'SRP54', 'NOX4', 'CDC42BPB', 'EIF2A']",0.9626517377585815,0,0,11
171,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7003071438707401,0.8403805496828752,0.2993740266975888,['RIPK2'],0.9626517377585815,0,0,1
172,"GPCRs, Other WP117",0.7003071438707401,0.8403805496828752,0.2993740266975888,['HTR1F'],0.9626517377585815,0,0,1
173,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7003071438707401,0.8403805496828752,0.2993740266975888,['SMAD3'],0.9626517377585815,0,0,1
174,B Cell Receptor Signaling Pathway WP23,0.7120299737480591,0.804368584387682,0.2731919417365915,"['MEF2C', 'E2F3']",0.9626517377585815,0,0,2
175,Vitamin D Receptor Pathway WP2877,0.7120299737480591,0.804368584387682,0.2731919417365915,"['GADD45A', 'HILPDA']",0.9626517377585815,0,0,2
176,Breast cancer pathway WP4262,0.7121072112490401,0.8155292690324537,0.27689404408834445,"['CSNK2A1', 'GADD45A', 'E2F3']",0.9626517377585815,0,0,3
177,"GPCRs, Class A Rhodopsin-like WP455",0.719057091351178,0.7931379472693032,0.2615884118379923,"['HRH1', 'HTR1F']",0.9626517377585815,0,0,2
178,Integrated Cancer Pathway WP1971,0.7202745198203755,0.7935752877613342,0.26039019472124036,['SMAD3'],0.9626517377585815,0,0,1
179,TGF-beta Signaling Pathway WP366,0.7237048697348448,0.8001666765878921,0.2587511850293612,"['MEF2C', 'SMAD3', 'E2F5']",0.9626517377585815,0,0,3
180,TGF-beta Receptor Signaling WP560,0.7297546574214024,0.7720701674190046,0.24323830283205491,['SMAD3'],0.9626517377585815,0,0,1
181,Wnt signaling WP428,0.7326787330191578,0.771587265231333,0.2400006476927994,"['CSNK2A1', 'CXXC4']",0.9626517377585815,0,0,2
182,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7389141576594603,0.7516968955157449,0.22744357934543594,['MEF2C'],0.9626517377585815,0,0,1
183,Endochondral Ossification WP474,0.7389141576594603,0.7516968955157449,0.22744357934543594,['MEF2C'],0.9626517377585815,0,0,1
184,Senescence and Autophagy in Cancer WP615,0.7392767752175721,0.7612429378531074,0.22995847539030678,"['SMAD3', 'CREG1']",0.9626517377585815,0,0,2
185,Circadian rhythm related genes WP3594,0.7416440146189708,0.79225768321513,0.23679466304134977,"['FBXW11', 'THRAP3', 'TNFRSF11A', 'HS3ST2']",0.9626517377585815,0,0,4
186,TNF-alpha signaling pathway WP231,0.7457353855022113,0.7511708296164139,0.22038184282608062,"['CSNK2A1', 'FBXW11']",0.9626517377585815,0,0,2
187,Prader-Willi and Angelman Syndrome WP3998,0.7477638430386601,0.7323684067870114,0.21287611039217064,['BBS4'],0.9626517377585815,0,0,1
188,Androgen receptor signaling pathway WP138,0.7520564283011535,0.7413603345806735,0.211246120025814,"['SMAD3', 'RNF4']",0.9626517377585815,0,0,2
189,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.7563141714784665,0.7140063424947146,0.19942084217884246,['TRAF5'],0.9626517377585815,0,0,1
190,ATM Signaling Network in Development and Disease  WP3878,0.7645752485078445,0.6965399886557005,0.18697559348614598,['TP53BP1'],0.9626517377585815,0,0,1
191,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7645752485078445,0.6965399886557005,0.18697559348614598,['SMAD3'],0.9626517377585815,0,0,1
192,Energy Metabolism WP1541,0.7645752485078445,0.6965399886557005,0.18697559348614598,['MEF2C'],0.9626517377585815,0,0,1
193,Eukaryotic Transcription Initiation WP405,0.7645752485078445,0.6965399886557005,0.18697559348614598,['ERCC2'],0.9626517377585815,0,0,1
194,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.7725568392734035,0.6799053659518776,0.17544937202007505,['SMAD3'],0.9644797972564089,0,0,1
195,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.7802683799494606,0.6640444466296278,0.16476094281598716,['CSNK2A1'],0.9644797972564089,0,0,1
196,Phosphodiesterases in neuronal function WP4222,0.7802683799494606,0.6640444466296278,0.16476094281598716,['PDE10A'],0.9644797972564089,0,0,1
197,Nuclear Receptors Meta-Pathway WP2882,0.7819033747305043,0.7617755378949409,0.1874151470521085,"['SULT1A1', 'ABCC4', 'GSTA4', 'MGST3', 'CES2']",0.9644797972564089,0,0,5
198,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.787718988811164,0.6489044781856621,0.15483760614597317,['RIPK2'],0.9667460317227922,0,0,1
199,Kit receptor signaling pathway WP304,0.8018723579440385,0.6205993197904219,0.1370319531573294,['MAPT'],0.9683924042644041,0,0,1
200,7q11.23 copy number variation syndrome WP4932,0.8081295057862795,0.6556594584063901,0.13967707115446476,"['EIF2A', 'ATPAF1']",0.9683924042644041,0,0,2
201,Gastrin signaling pathway WP4659,0.8130671015289862,0.6481606317411402,0.13413142225844912,"['MEF2C', 'ELAVL1']",0.9683924042644041,0,0,2
202,DNA IR-double strand breaks and cellular response via ATM WP3959,0.8150839311068181,0.594652924594785,0.12158522742291618,['TP53BP1'],0.9683924042644041,0,0,1
203,Nonalcoholic fatty liver disease WP4396,0.8163116992755061,0.678546153068446,0.13771705719585897,"['SDHD', 'NDUFV3', 'NDUFV2']",0.9683924042644041,0,0,3
204,Translation Factors WP107,0.8213562548685169,0.5824740044009147,0.114629914638863,['EIF5B'],0.9683924042644041,0,0,1
205,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8243358671222345,0.667844347133758,0.12901231863983859,"['MEF2C', 'CSNK2A1', 'MAPT']",0.9683924042644041,0,0,3
206,AGE/RAGE pathway WP2324,0.8274162536891906,0.5707822410147991,0.10813320059786935,['SMAD3'],0.9683924042644041,0,0,1
207,Thermogenesis WP4321,0.831700989134064,0.6197955047899779,0.11421733546035058,"['SLC25A29', 'MGLL']",0.9683924042644041,0,0,2
208,3q29 copy number variation syndrome WP4906,0.8332711002561658,0.5595489781536294,0.10205962930551576,['DYNLT1'],0.9683924042644041,0,0,1
209,Regulatory circuits of the STAT3 signaling pathway WP4538,0.8443928267810169,0.5383541425665164,0.09105585122731628,['JAK3'],0.9683924042644041,0,0,1
210,DNA damage response WP707,0.8496728753427746,0.5283454702059354,0.0860695144550257,['GADD45A'],0.9683924042644041,0,0,1
211,Oncostatin M Signaling Pathway WP2374,0.8496728753427746,0.5283454702059354,0.0860695144550257,['JAK3'],0.9683924042644041,0,0,1
212,Proteasome Degradation WP183,0.8496728753427746,0.5283454702059354,0.0860695144550257,['PSMA1'],0.9683924042644041,0,0,1
213,Mesodermal commitment pathway WP2857,0.85263129488435,0.5876288659793815,0.09368453603137947,"['SMAD3', 'HPRT1']",0.9683924042644041,0,0,2
214,Endometrial cancer WP4155,0.8597026166053199,0.5094004832376925,0.07700543133588758,['GADD45A'],0.9683924042644041,0,0,1
215,miRNA regulation of DNA damage response WP1530,0.8597026166053199,0.5094004832376925,0.07700543133588758,['GADD45A'],0.9683924042644041,0,0,1
216,AMP-activated protein kinase (AMPK) signaling WP1403,0.8644641902092162,0.5004265420422092,0.07288482251641644,['ELAVL1'],0.9683924042644041,0,0,1
217,Head and Neck Squamous Cell Carcinoma WP4674,0.8735089581181051,0.4833912638406135,0.06537233312333675,['SESN2'],0.9683924042644041,0,0,1
218,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.8746045161334761,0.5531512259338489,0.07411312420381044,"['SMAD3', 'MMP15']",0.9683924042644041,0,0,2
219,Focal Adhesion WP306,0.8811838744743349,0.5887985943334065,0.07447652404202815,"['MYL5', 'ACTN4', 'PARVB']",0.9683924042644041,0,0,3
220,MECP2 and Associated Rett Syndrome WP3584,0.881951316211308,0.46747305306207326,0.05872322703725026,['MEF2C'],0.9683924042644041,0,0,1
221,Ectoderm Differentiation WP2858,0.8844228259316688,0.5373760793092421,0.06600054124933241,"['ABCC4', 'PI4KA']",0.9683924042644041,0,0,2
222,T-cell receptor (TCR) signaling pathway WP69,0.8898313075158093,0.4525655223329642,0.05282497578105378,['RIPK2'],0.9683924042644041,0,0,1
223,16p11.2 proximal deletion syndrome WP4949,0.8935721978967492,0.44546115221987315,0.050126916764127956,['ASPHD1'],0.9683924042644041,0,0,1
224,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8935721978967492,0.44546115221987315,0.050126916764127956,['SEC23B'],0.9683924042644041,0,0,1
225,DNA Repair Pathways Full Network WP4946,0.9019598977977947,0.5083610774818402,0.0524553491680126,"['LIG1', 'ERCC2']",0.9683924042644041,0,0,2
226,Alzheimer's disease WP2059,0.9040512560231723,0.4254204663784671,0.04291183106513946,['MAPT'],0.9683924042644041,0,0,1
227,Hepatitis B infection WP4666,0.9046299414321799,0.503824808759562,0.05049801969475005,"['SMAD3', 'JAK3']",0.9683924042644041,0,0,2
228,Amino Acid metabolism WP3925,0.9104587089664335,0.41302815822532707,0.03874482120498648,['SMS'],0.9693476579485866,0,0,1
229,DNA IR-damage and cellular response via ATR WP4016,0.9135004677787092,0.40709755360918154,0.036830681984839214,['TP53BP1'],0.9693476579485866,0,0,1
230,Wnt signaling pathway and pluripotency WP399,0.9246705867114495,0.38497800125707105,0.03015060214608654,['CTNND1'],0.9746171235390986,0,0,1
231,PI3K-Akt signaling pathway WP4172,0.9264878828705011,0.5539802802283342,0.042298783010766866,"['GNG7', 'COL9A3', 'SGK3', 'JAK3']",0.9746171235390986,0,0,4
232,Hippo-Merlin Signaling Dysregulation WP4541,0.9366307093208794,0.3604784970696069,0.023599155468811642,['CDH9'],0.9770531884672539,0,0,1
233,Integrated breast cancer pathway WP1984,0.9373339397580428,0.444286281779661,0.02875228339836203,"['GADD45A', 'DCAKD']",0.9770531884672539,0,0,2
234,22q11.2 copy number variation syndrome WP4657,0.940866033338837,0.35152559183566934,0.021427072242691633,['PI4KA'],0.9770531884672539,0,0,1
235,DNA damage response (only ATM dependent) WP710,0.9466952143708218,0.3388956005235075,0.01856405063031944,['SMAD3'],0.978923136562169,0,0,1
236,Ras signaling WP4223,0.9555254701731705,0.40584140435835353,0.018463291737809567,"['GNG7', 'PLA2G4C']",0.9798076839238241,0,0,2
237,Ebola Virus Pathway on Host WP4217,0.95668925698367,0.31616161616161614,0.013998575832247848,['ACTN4'],0.9798076839238241,0,0,1
238,Insulin Signaling WP481,0.9615086989045266,0.39170075978959673,0.015374907697456289,"['ARHGAP33', 'SGK3']",0.9798076839238241,0,0,2
239,EGF/EGFR signaling pathway WP437,0.9636791623777529,0.38631384757292747,0.014292398901418856,"['MEF2C', 'PTPRR']",0.9798076839238241,0,0,2
240,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9722386170389888,0.41875058830912115,0.011789509870813253,"['GNG7', 'JAK3', 'ELAVL1']",0.9823216434236651,0,0,3
241,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.9742366916259395,0.2706936474378335,0.007065373532575011,['MEF2C'],0.9823216434236651,0,0,1
242,Fragile X Syndrome  WP4549,0.9824039132024871,0.24482394109499162,0.004346295353011623,['AGO2'],0.9864634335049768,0,0,1
243,IL-18 signaling pathway WP4754,0.9980953725459857,0.1570237256283768,0.0002993568710029578,['ELAVL1'],0.9980953725459857,0,0,1
